PT Kimia Farma (Persero) Tbk (KAEF.JK)
IDR 396.0
(0.51%)
IDR 396.0
(0.51%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 7926.98 Billion IDR | -2.3% |
| 2022 | 8113.23 Billion IDR | 1.11% |
| 2021 | 8023.94 Billion IDR | 3.39% |
| 2020 | 7760.94 Billion IDR | -6.46% |
| 2019 | 8296.65 Billion IDR | 105.38% |
| 2018 | 4039.62 Billion IDR | 100.03% |
| 2017 | 2019.5 Billion IDR | 145.56% |
| 2016 | 822.39 Billion IDR | 153.31% |
| 2015 | 324.66 Billion IDR | -3.49% |
| 2014 | 336.4 Billion IDR | 559.82% |
| 2013 | 50.98 Billion IDR | 83.04% |
| 2012 | 27.85 Billion IDR | 12.42% |
| 2011 | 24.77 Billion IDR | -48.42% |
| 2010 | 48.03 Billion IDR | -29.58% |
| 2009 | 68.21 Billion IDR | -54.64% |
| 2008 | 150.38 Billion IDR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 7584.65 Billion IDR | 1.63% |
| 2024 Q3 | 7658.96 Billion IDR | -0.34% |
| 2024 Q1 | 7463.25 Billion IDR | -5.85% |
| 2023 FY | 7926.98 Billion IDR | -2.3% |
| 2023 Q4 | 7926.98 Billion IDR | -0.95% |
| 2023 Q3 | 8002.71 Billion IDR | -0.1% |
| 2023 Q2 | 8010.54 Billion IDR | 4.83% |
| 2023 Q1 | 7641.78 Billion IDR | -5.81% |
| 2022 Q1 | 8313.66 Billion IDR | 3.61% |
| 2022 Q4 | 8113.23 Billion IDR | -8.67% |
| 2022 FY | 8113.23 Billion IDR | 1.11% |
| 2022 Q2 | 8974.8 Billion IDR | 7.95% |
| 2022 Q3 | 8883.59 Billion IDR | -1.02% |
| 2021 Q2 | 8020.64 Billion IDR | 3.01% |
| 2021 FY | 8023.94 Billion IDR | 3.39% |
| 2021 Q1 | 7786.48 Billion IDR | 0.33% |
| 2021 Q4 | 8023.94 Billion IDR | -3.67% |
| 2021 Q3 | 8329.46 Billion IDR | 3.85% |
| 2020 Q4 | 7760.94 Billion IDR | -6.0% |
| 2020 FY | 7760.94 Billion IDR | -6.46% |
| 2020 Q3 | 8256.69 Billion IDR | 2.41% |
| 2020 Q2 | 8062.51 Billion IDR | 1.52% |
| 2020 Q1 | 7941.71 Billion IDR | -4.28% |
| 2019 Q4 | 8296.65 Billion IDR | 8.52% |
| 2019 FY | 8296.65 Billion IDR | 105.38% |
| 2019 Q1 | 6863.56 Billion IDR | 69.91% |
| 2019 Q2 | 6809.45 Billion IDR | -0.79% |
| 2019 Q3 | 7645.46 Billion IDR | 12.28% |
| 2018 Q2 | 3465.31 Billion IDR | 40.86% |
| 2018 FY | 4039.62 Billion IDR | 100.03% |
| 2018 Q1 | 2460.09 Billion IDR | 21.82% |
| 2018 Q4 | 4039.62 Billion IDR | -3.23% |
| 2018 Q3 | 4174.3 Billion IDR | 20.46% |
| 2017 Q3 | 1894.04 Billion IDR | 41.04% |
| 2017 Q2 | 1342.89 Billion IDR | 27.32% |
| 2017 Q1 | 1054.71 Billion IDR | 28.25% |
| 2017 FY | 2019.5 Billion IDR | 145.56% |
| 2017 Q4 | 2019.5 Billion IDR | 6.62% |
| 2016 Q3 | 874.35 Billion IDR | 46.2% |
| 2016 Q4 | 822.39 Billion IDR | -5.94% |
| 2016 Q1 | 502.52 Billion IDR | 54.78% |
| 2016 Q2 | 598.06 Billion IDR | 19.01% |
| 2016 FY | 822.39 Billion IDR | 153.31% |
| 2015 Q2 | 387.18 Billion IDR | 46.41% |
| 2015 Q1 | 264.45 Billion IDR | -21.39% |
| 2015 FY | 324.66 Billion IDR | -3.49% |
| 2015 Q3 | 404.12 Billion IDR | 4.37% |
| 2015 Q4 | 324.66 Billion IDR | -19.66% |
| 2014 Q4 | 336.4 Billion IDR | 7.9% |
| 2014 Q3 | 311.78 Billion IDR | 11.95% |
| 2014 Q2 | 278.51 Billion IDR | 389.83% |
| 2014 Q1 | 56.85 Billion IDR | 11.52% |
| 2014 FY | 336.4 Billion IDR | 559.82% |
| 2013 Q2 | 50.1 Billion IDR | 176.0% |
| 2013 Q4 | 50.98 Billion IDR | -64.59% |
| 2013 FY | 50.98 Billion IDR | 83.04% |
| 2013 Q3 | 143.96 Billion IDR | 187.34% |
| 2013 Q1 | 18.15 Billion IDR | -34.83% |
| 2012 Q3 | 85.09 Billion IDR | 65.32% |
| 2012 Q4 | 27.85 Billion IDR | -67.27% |
| 2012 Q1 | 29.8 Billion IDR | 20.32% |
| 2012 FY | 27.85 Billion IDR | 12.42% |
| 2012 Q2 | 51.46 Billion IDR | 72.67% |
| 2011 FY | 24.77 Billion IDR | -48.42% |
| 2011 Q4 | 24.77 Billion IDR | 0.0% |
| 2010 FY | 48.03 Billion IDR | -29.58% |
| 2009 FY | 68.21 Billion IDR | -54.64% |
| 2008 FY | 150.38 Billion IDR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | 3.08 Billion IDR | -256536.631% |
| PT Itama Ranoraya Tbk | 240.86 Billion IDR | -3191.096% |
| PT Millennium Pharmacon International Tbk | 710.33 Billion IDR | -1015.948% |
| PT Soho Global Health Tbk | 19.94 Billion IDR | -39640.23% |